HCA Healthcare, Inc. HCA
504.89 USD +9.90 (+2.00%)
At closeNov 10, 2026, 5:04 AM EST
506.51 +1.62 +0.32%
Pre-market · Nov 10, 5:04 AM ET
498.14 Day range 507.28
353.99 52-week range 556.52
- YTD
- +8.15%
- 1 year
- +9.93%
News
fool.com HCA Healthcare: 3 Key Takeaways for Long-Term Investors Same facility equivalent admissions increased 3% in the third quarter. HCA Healthcare repurchased approximately $3 billion of outstanding shares.
zacks.com HCA Healthcare (HCA) Just Flashed Golden Cross Signal: Do You Buy? HCA Healthcare (HCA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HCA broke through the 20-day moving average, which suggests a…
barrons.com Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing. The stocks of big operators in state Medicaid programs, Affordable Care Act markets and hospital groups all jumped.
zacks.com Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
benzinga.com Truist Securities Reiterates Buy on HCA Healthcare, Raises Price Target to $510 Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.
invezz.com 2 stocks to buy and 1 to sell as Democrats push for control of Congress Americans are voting today, with control of Congress and the next round of battles over healthcare, energy incentives, and federal spending, at stake. For investors, the opportunity lies in…
seekingalpha.com Conventum - Alluvium Global Fund Q3 2026 Performance Update The Fund was down 3.2% in EUR terms, 3.8% in USD and 4.2% in AUD terms. Once again, for the third consecutive quarter, the most notable highlight for investors is a new position - this time, it is…
benzinga.com Here’s How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years HCA Healthcare (NYSE:HCA) has outperformed the market over the past 15 years by 8.97% on an annualized basis producing an average annual return of 21.51%. Currently, HCA Healthcare has a market…
benzinga.com Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $468 Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $381 to $468.
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
benzinga.com RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521 RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
benzinga.com Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $401 Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.
benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $486 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $460 to $486.
benzinga.com HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
benzinga.com Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490 Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.- benzinga.com Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409 Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.
- benzinga.com B of A Securities Maintains Neutral on HCA Healthcare, Raises Price Target to $500 B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $450 to $500.
benzinga.com HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
benzinga.com HCA Healthcare Q3 2026 Earnings Call Transcript HCA Healthcare (NYSE:HCA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250…
benzinga.com Visa, Coca-Cola On Deck Tuesday As Payments Growth, Global Demand Face Test Visa is Tuesday’s most material report, with investors looking for continued payments growth after a strong run in the stock. Coca-Cola, HSBC Holdings, Novartis, Boeing and S&P Global report before…- benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $460 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $431 to $460.
tradingkey.com HIMS News Get the latest Hims & Hers Health Inc (HIMS) stock news, including earnings updates, analyst ratings, company announcements and market-moving events.
finance.sina.com.cn HCA控股收涨2%，成交额4.81亿美元 11月10日，HCA控股（HCA）收涨2%，报504.89美元，成交额4.81亿美元，市值1054.68亿美元。 公司最新财报显示，季度营收198.49亿美元，同比增长3.59%；净利润15.79亿美元，同比下降3.9%。 公司简介…- finance.sina.com.cn 内部人交易｜HCA控股披露一笔股票减持，金额约59.36万美元 美股上市公司HCA控股（HCA）披露一笔内部人股票交易。文件显示，公司内部人Schlosser (Michael J M.D.)（Officer）2026-11-04减持公司股票，交易金额约593580.00美元。…
finance.yahoo.com Take the Zacks Approach to Beat the Markets: Ulta Beauty, Accenture, HCA in Focus Zacks highlights how its research strategies have delivered strong returns, with ACN, HCA and ULTA among the standout ...
- finance.yahoo.com ReMedi Health Solutions Expands Healthcare Optimization Services to Advance Enterprise-Wide Performance Improvement Physician-led ReMedi Health Solutions expands its healthcare optimization services to help health systems get more value from EHR and AI investments.
- marketwatch.com HCA Healthcare Inc. stock rises Monday, still underperforms market The stock's rise snapped a two-day losing streak. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the…
ad-hoc-news.de HCA Healthcare stock weighs resilient demand against 2027 payer risks HCA Healthcare stock faces a tougher 2027 as coverage losses pressure payer mix. Management still expects volume growth and ...
durangoherald.com From high-flying AI stocks to tariff-hit alcohol companies, the midterms shook up Wall Street Enter your email, confirm it from your inbox, and receive Breaking News and Local News newsletters plus 3 free articles each ...